Stock Analysis

Axcelis Technologies Second Quarter 2025 Earnings: Beats Expectations

NasdaqGS:ACLS
Source: Shutterstock
NasdaqGS:ACLS 1 Year Share Price vs Fair Value
NasdaqGS:ACLS 1 Year Share Price vs Fair Value
Explore Axcelis Technologies's Fair Values from the Community and select yours
Advertisement

Axcelis Technologies (NASDAQ:ACLS) Second Quarter 2025 Results

Key Financial Results

  • Revenue: US$194.5m (down 24% from 2Q 2024).
  • Net income: US$31.4m (down 38% from 2Q 2024).
  • Profit margin: 16% (down from 20% in 2Q 2024). The decrease in margin was driven by lower revenue.
  • EPS: US$0.98 (down from US$1.56 in 2Q 2024).
earnings-and-revenue-growth
NasdaqGS:ACLS Earnings and Revenue Growth August 6th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Axcelis Technologies Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 5.1%. Earnings per share (EPS) also surpassed analyst estimates by 68%.

Looking ahead, revenue is expected to decline by 1.9% p.a. on average during the next 3 years, while revenues in the Semiconductor industry in the US are expected to grow by 17%.

Performance of the American Semiconductor industry.

The company's shares are up 6.6% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 1 warning sign for Axcelis Technologies you should know about.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:ACLS

Axcelis Technologies

Designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and the Asia Pacific.

Flawless balance sheet and slightly overvalued.

Advertisement